25 results
8-K
EX-10.1
TVTX
Travere Therapeutics Inc
17 Jul 23
Entry into a Material Definitive Agreement
8:07am
, distributor, supplier or collaboration partner;
(10) the announcement, execution, delivery or pendency of this Agreement and the transactions … , supplier, licensor, lessor, distributor, independent contractor or customer of the Specified Business; (ii) owns, directly or indirectly any property
8-K
EX-1.1
TVTX
Travere Therapeutics Inc
11 Mar 22
Travere Announces Proposed Convertible Senior Notes Offering
4:06pm
, or with the employees of any principal supplier, manufacturer, customer or contractor of the Company, exists or, to the knowledge of the Company, is threatened
8-K
EX-10.1
x7qqamyp8
12 Oct 21
Departure of Directors or Certain Officers
5:15pm
8-K
EX-1.1
tf05 62hq32xrbiv7m
12 Feb 21
Travere Therapeutics Announces Proposed Public Offering of Common Stock
4:46pm
8-K
EX-2.1
bqpk nglw
18 Nov 20
Completion of Acquisition or Disposition of Assets
5:18pm
8-K
vp08qwfd2ohcfunqa
6 Oct 20
Entry into a Material Definitive Agreement
5:26pm
8-K
EX-1.1
bx4 c6cy91q6
9 Jun 20
Retrophin Announces Proposed Public Offering of Common Stock
4:08pm
8-K
EX-10.1
1ge4uv7n58sl
19 Apr 19
Departure of Directors or Certain Officers
5:18pm
8-K
EX-10.1
53btmyc9
7 Jul 14
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.1
4t2818wls9g91
4 Jun 14
Retrophin Names Alvin Shih, M.D. Executive Vice President of Research and Development
12:00am